Alzheimer’s disease (AD) is the most prevalent cause of dementia in the elderly, characterized by the presence of amyloid-beta (Aβ) plaques, neurofibrillary tangles, neuroinflammation, synapse loss and neurodegeneration in the brain. The amyloid cascade hypothesis postulates that deposition of Aβ peptides is the causative agent of AD pathology, but we still lack comprehensive understanding of the molecular mechanisms connecting Aβ peptides to neuronal dysfunctions in AD. In this work, we investigate the early effects of Aβ peptide accumulation on the functional properties and gene expression profiles of human-induced neurons (hiNs). We show that hiNs acutely exposed to low concentrations of both cell-secreted Aβ peptides or synthetic Aβ1–42 exhibit alterations in the frequency of calcium transients suggestive of increased neuronal excitability. Using single-cell RNA sequencing, we also show that cell-secreted Aβ up-regulates the expression of several synapse-related genes and down-regulates the expression of genes associated with metabolic stress mainly in glutamatergic neurons and, to a lesser degree, in GABAergic neurons and astrocytes. These neuronal alterations correlate with activation of the SEMA5, EPHA and NECTIN signaling pathways, which are important regulators of synaptic plasticity. Altogether, our findings indicate that slight elevations in Aβ concentrations are sufficient to elicit transcriptional changes in human neurons, which can contribute to early alterations in neural network activity.
Background: The allele e4 of the apolipoprotein E gene ( APOE4 ), present in around 20% of the population, is the leading genetic risk factor of late‐onset Alzheimer's disease (AD), with APOE4 homozygote ( APOE 44) having more than 90% chance undergoing AD biology at 65 years old (Forta et al., Nature Medicine, 2024). Despite this near full penetrance, major gaps remain in our understanding of APOE4‐mediated neuropathology. Method: We compared human iPSC‐derived mixed cortical culture (hiMCC, mix of neurons and astrocytes) from APOE 44 and AD neutral APOE3 allele carriers using proteomics and deeply sequenced transcriptomics data. We further validated our findings using APOE genotype CRISPR/Cas9‐edited isogenics hiMCC and postmortem brain multi‐omics data from large and highly phenotyped brain bank cohorts. Result: While transcriptomics and proteomics integration confirm impacts of APOE4 in extracellular matrix and lipid transport pathways, we found that APOE4 induces in addition a robust reduction of the mRNA spliceosome machinery at protein level. In line with this, we further observed that APOE4 induces important mRNA splicing defects, more specifically intron retention in genes regulating neuronal projection and are associated with concordant protein reduction. By analyzing scRNA‐seq data from isogenics hiMCC, we found that APOE 4 induces this splicing defect specifically in a subpopulation of excitatory neurons with intense mRNA splicing activity for actin based projection. Finally, we confirmed these splicing defect with impact on neuronal projection genes observable also in APOE4 carrier postmortem brains even at early stage of disease progression, and found strong association with amyloid plaque and neurofibrillary tangles burden. Conclusion: Disruption of the excitatory neurons mRNA splicing activity for effective cell projection is one key element of APOE4 mediated neuropathology and appear early in the disease progression.